激素是一类由生物体内的内分泌腺或细胞分泌的化学物质,它们在体内通过血液循环传递信息,调控多种生理过程。主要分为甾体激素、胺类激素和肽类激素等几大类。
调节内分泌功能的药物主要用于治疗由于体内激素失衡引起的各种疾病,常见的类型有:
替代疗法:
抑制或刺激腺体分泌的药物:
调节胰岛素分泌或作用的药物:
抑制或促进激素生成与释放的药物:
综上所述,调节内分泌功能类药物在治疗多种疾病方面发挥着重要作用。但使用时需遵循医嘱,在专业医生指导下进行,以确保安全性和有效性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | [(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | 80474-14-2 | C25H31F3O5S |
| —— | (3aR-(3aalpha,4alpha,5beta,6aalpha))-Hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta(b)furan-5-yl benzoate | 39746-00-4 | C15H16O5 |
| —— | deamino-Cys(1)-DL-Tyr-DL-xiIle-DL-Gln-DL-Asn-DL-Cys(1)-Pro-Leu-Gly-NH2 | 113-78-0 | C43H65N11O12S2 |
| —— | Cycrin | 71-58-9 | C24H34O4 |
| —— | (8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl butyrate | 13609-67-1 | C25H36O6 |
| —— | ICI 80996 sodium salt | 55028-72-3 | C22H28ClNaO6 |
| —— | 3,20-Dioxo-17α-methyl-19-norpregna-4,9-dien | 10116-22-0 | C21H28O2 |
| —— | Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys)-OH | 51110-01-1 | C76H104N18O19S2 |
| —— | SRIF-D-Trp8 | 51110-01-1 | C76H104N18O19S2 |
| —— | Pharmakon1600-01505979 | 297-76-7 | C24H32O4 |
| —— | beta-Methasone 17,21-dipropionate | 5593-20-4 | C28H37FO7 |
| —— | Methylergometrine maleate | 57432-61-8 | C24H27N3O6-2 |
| —— | 4-[(2R)-1-hydroxy-2-(methylamino)propyl]phenol | 365-26-4 | C10H15NO2 |
| —— | Humulin N | 11061-68-0 | C257H383N65O77S6 |
| —— | 15(S)-15-methyl-PGF2alpha | 58551-69-2 | C21H36O5 |
| —— | Pituitrin | 11000-17-2 | C92H130N28O24S4 |
| —— | boldenone | 846-48-0 | C19H26O2 |
| —— | 17β-hydroxy-androsta-1,4-dien-3-one | 846-48-0 | C19H26O2 |
| —— | 17β-hydroxy-(10α)-androsta-1,4-dien-3-one | 846-48-0 | C19H26O2 |
| —— | Trestolone | 3764-87-2 | C19H28O2 |
| —— | 11β,17β-Dihydroxy-androst-4-en-3-on | 1816-85-9 | C19H28O3 |
| —— | Deaminooxytocin | 113-78-0 | C43H65N11O12S2 |
| —— | 17α-Methyl-5β-androst-1-en-17β-ol-3-on | 65-04-3 | C20H30O2 |
| —— | 17β-Hydroxy-17α-methyl-androst-1-en-3-on | 65-04-3 | C20H30O2 |
| —— | 17α-Methyl-Δ<sup>1</sup>-5α-androstenol-(17β)-on-(3) | 65-04-3 | C20H30O2 |
| —— | 15-Ethyl-14-ethynyl-5-(hydroxyimino)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-ol | 53016-31-2 | C21H29NO2 |
| —— | (2S)-2-amino-3-{[(3-chloro-2-methyl-5-sulfophenyl)carbamoyl]amino}propanoic acid | 1333218-50-0 | C11H14ClN3O6S |
| —— | octreotide diacetate | 79517-01-4 | 2C2H4O2*C49H66N10O10S2 |
| —— | S-Fluoromethyl 6α,9α-Difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate | 80474-14-2 | C25H31F3O5S |
| —— | Liraglutide | 204656-20-2 | C172H265N43O51 |
| —— | 19-Norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-, (17alpha)- | 68-23-5 | C20H26O2 |
| —— | (6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate | 71-58-9 | C24H34O4 |
| —— | beraprost sodium | 88475-69-8 | C24H29O5*Na |
| —— | (+/-)-15-Deoxy-[16RS]-16-hydroxy-16-methylprostaglandin E1 | 112137-89-0 | C21H36O5 |
| —— | Sodium 4-(2-hydroxy-1-(3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate | 88475-69-8 | C24H29NaO5 |
| —— | Dtxcid7028691 | 337-03-1 | C21H29FO4 |
| —— | 17-beta-Hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-androstan-3-one | 434-07-1 | C21H32O3 |
| —— | Unii-S7RL72610R | 12542-36-8 | C33H36O9 |
| —— | prednisolone sodium succinate | 1715-33-9 | C25H31O8*Na |
| —— | Glymidine sodium | 3459-20-9 | C13H14N3NaO4S |
| —— | (3R,4R,6R)-5-[(3R,4R,6R)-5-[(3R,4S,6R)-3,4-Dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol | 56180-94-0 | C25H43NO18 |
| —— | Celestone Phosphate | 151-73-5 | C22H30FNaO8P+ |
| —— | (2R,5S,6R)-5-[(5S,6R)-5-[(2R,3R,6R)-3,4-dihydroxy-6-methyl-5-[[(4R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol | 56180-94-0 | C25H43NO18 |
| —— | (Z)-7-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxy-4-phenoxybut-1-enyl)-5-oxocyclopentyl)-N-(methylsulfonyl)hept-5-enamide | 60325-46-4 | C23H31NO7S |
| —— | 5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid | 78919-13-8 | C22H32O4 |
| —— | goserelin | 65807-02-5 | C59H84N18O14 |
| —— | 17α-Ethinyl-17β-hydroxy-18-methyl-11-methylen-Δ<sup>4</sup>-estren-3-on | 54048-10-1 | C22H28O2 |
| —— | (17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | 16320-04-0 | C21H24O2 |
| —— | (8R,9S,10R,13S,14S)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | 6533-00-2 | C21H28O2 |
| —— | somatostatin | 51110-01-1 | C76H104N18O19S2 |